Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer

Biomaterials

Volumn 35, Issue 21, 2014, Pages 5539-5548

  Kesharwani, Prashant ^a   Tekade, Rakesh K ^b   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

Cancer; Dendrimer; Drug delivery; Generations; Toxicity

Indexed keywords

BIOCOMPATIBILITY; DENDRIMERS; DISEASES; DRUG DELIVERY; ENZYME INHIBITION; TOXICITY;

ANTI-CANCER DRUG DELIVERY; ANTICANCER POTENTIALS; CANCER; FLOW CYTOMETRY ASSAYS; GENERATIONS; KAPLAN-MEIER SURVIVAL CURVES; POLY(PROPYLENE IMINE); THERAPEUTIC POTENTIALS;

LOADING;

DENDRIMER; DRUG CARRIER; POLY(PROPYLENEIMINE); POLYPROPYLENE;

ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; KAPLAN MEIER METHOD; MCF 7 CELL LINE; MOUSE; NEOPLASMS; PROCEDURES; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MCF-7 CELLS; MICE; MICE, INBRED BALB C; NEOPLASMS; POLYPROPYLENES;

EID: 84899475562     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.064     Document Type: Article

References (24)

1. Kesharwani P., Ghanghoria R., Jain N.K. Carbon nanotube exploration in cancer cell lines. Drug Discov Today 2012, 17:1023-1030.
2. Kesharwani P., Tekade R.K., Jain K., Jain N.K. Formulation development and invitro-invivo assessment of fourth generation PPI dendrimer as cancer targeting vector. Nanomed (Lond) 2014, [Epub ahead of print].
3. Akhter S., Ahmad I., Ahmad M.Z., Ramazani F., Singh A., Rahman Z., et al. Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets 2013, 13:362-378.
4. Mignani S., El Kazzouli S., Bousmina M., Majoral J.P. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview. Adv Drug Deliv Rev 2013, 65:1316-1330.
5. Koo O.M., Rubinstein I., Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 2005, 1:193-212.
6. Kesharwani P., Jain K., Jain N.K. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 2014, 39:268-307.
7. Kesharwani P., Gajbhiye V., Tekade R.K., Jain N.K. Evaluation of dendrimer safety and efficacy through cell line studies. Curr Drug Targets 2011, 12:1478-1497.
8. Barrière C., Latour V., Fau P., Caminade A.M., Turrin C.O. Low generation PEGylated phosphorus-containing dendrons with phosphonate anchors. Tetrahedron Lett 2012, 53:1908-1911.
9. D'Emanuele A., Attwood D. Dendrimer drug interaction. Adv Drug Deliv Rev 2005, 57:2147-2162.
10. Tekade R.K., Kumar P.V., Jain N.K. Dendrimers in oncology: an expanding horizon. Chem Rev 2009, 109:49-87.
11. Tekade R.K., Dutta T., Tyagi A., Bharti A.C., Das B.C., Jain N.K. Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy. JDrug Target 2008, 16:758-772.
12. Kesharwani P., Tekade R.K., Gajbhiye V., Jain K., Jain N.K. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomedicine 2011, 7:295-304.
13. Tomalia D.A., Naylor A.M., Goddard W.A. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl 1990, 29:138-175.
14. Fréchet J.M.J. Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. Science 1994, 263:1710-1715.
15. Mishra V., Gupta U., Jain N.K. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes. Pharmazie 2010, 65:891-895.
16. Thakur S., Tekade R.K., Kesharwani P., Jain N.K. The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers. JNanopart Res 2013, 15:1625-1640.
17. Pinguet F., Joulia J.M., Martel P., Grosse P.Y., Astre C., Bressolle F. High-performance liquid chromatographic assay for melphalan in human plasma. Application to pharmacokinetic studies. JChromatogr B Biomed Appl 1996, 686:43-49.
18. Sashidhara K.V., Rosaiah J.N., Kumar A., Bid H.K., Konwar R., Chattopadhyay N. Cell growth inhibitory action of an unusual labdanediterpene, 13-epi-sclareol in breast and uterine cancers invitro. Phytother Res 2007, 21:1105-1108.
19. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991, 3:207-212.
20. Trasler J., Deng L., Melnyk S., Pogribny I., Tim F.H., Sibani S., et al. Impact of Dnmt1 defi{ligature}ciency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis 2003, 24:39-45.
21. Dendrimers: design, synthesis and chemical properties. Dendrimers in medicine and biotechnology new molecular tools. The Royal Society of Chemistry UK 2006, 1-27. 1st ed. U. Boas, J.B. Christensen, P.M.H. Heegaard (Eds.).
22. 125I labeled polyamodoamine dendrimers invivo. JControl Release 2000, 65:133-148.
23. Arias J.T., López-Viota M., Gallardo V., Adolfina Ruiz M. Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur. Drug Dev Ind Pharm 2010, 36:744-750.
24. Ziemba B., Halets I., Shcharbin D., Appelhans D., Voit B., Pieszynski I., et al. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells. JBiomed Mater Res A 2012, 100:287080.